Saturday, March 30, 2019

FDA Suggests Congress Holds the Key to Legalizing CBD-Infused Foods

fda cbd foodDuring a recent interview with the Brookings Institution, Scott Gottlieb, the departing head of the Food and Drug Administration (“FDA”), explained it would take several years for the agency to come up with rules that would legalize the use of hemp-derived cannabidiol (Hemp-CBD) in food products, unless Congress steps in.

Gottlieb acknowledged the strong interest among CBD stakeholders and lawmakers in developing a regulatory framework through which Hemp-CBD could be infused to food. The problem, Gottlieb explained, is that CBD has been approved as a drug (i.e., Epidiolex) and was not previously used in the food supply.

The FDA Commissioner further argued that putting a drug that wasn’t previously used in food into the food supply would require the agency to go through a formal rulemaking process.

As we previously discussed, thus far, the FDA has only adopted informal, non-binding guidelines as its primary method of policy making for CBD as they afford the agency more flexibility. Adopting regulations through the formal rulemaking process would take two to three years, possibly longer, given the controversial nature of CBD as a compound closely associated with marijuana and that is used as a drug ingredient. Gottlieb suggested that a more efficient way of clarifying the situation would be for Congress to issue additional legislation that expressly allow the use of Hemp-CBD in foods. While the congressional intend behind the 2018 Farm Bill was to legalize the production of Hemp-CBD, lawmakers failed to define the meaning of “production,” thus, leaving open for interpretation whether the sale of Hemp-CBD and its use in food product was legal.

Similarly to a statement made in front of a House Appropriations subcommittee last month, the Commissioner suggested that the approval of Hemp-CBD infused food may turn on whether the CBD infused to food is an isolate or is used in its naturally-occurring form (see here for more background information on this distinction).

I think you need to come up with a framework that defines concentration levels, where you would create some kind of cut off, and that would be up to the agency to do….CBD in high concentrations isn’t risk-free, and in low concentration, it probably is safe—I don’t want to make a declaration here. It’s also a question of whether it’s providing any kind of therapeutic benefit in those concentrations, although people seem to believe that it has some value.”

During the interview, the Commissioner also shared that the Drug Enforcement Administration (“DEA”) would have to “formally deschedule” Hemp-CBD before moving forward with regulatory changes, even though the 2018 Farm Bill removed Hemp-CBD from the Controlled Substance Act and shifted its regulation from the Department of Justice (which oversees the DEA) to the U.S. Department of Agriculture.

I think the prevailing view is that the plain language of the statute [the Farm Bill] intended for that, but I’m not sure that DEA has done that yet. But that’s another step that would have to take place. DEA would have to formally de-schedule CBD derived from hemp.”

For now, Gootlieb explained that the agency is creating a “high-level work group” tasked with identifying “some potential legislative pathways to create a framework for allowing CBD into the food supply.” The work group will be formally announced in the next few days and will hold a public meeting to solicit comments from Hemp-CBD stakeholders. According to the Commissioner, the work group should release recommendations by the summer.



source https://www.cannalawblog.com/fda-suggests-congress-holds-the-key-to-legalizing-cbd-infused-foods/

Thursday, March 28, 2019

Cannabis Agency Litigation: Free Webinar April 23

cannabis litigation

Those who have been running businesses in the cannabis industry for years, as well as those that are working hard to become licensed, know it is not a simple task to stay in compliance with state and local regulations. The complexity of such regulations can cause businesses to inadvertently make mistakes, which can lead to really serious violations that at times end up in monetary penalties, or even worse–license revocation.

To avoid losing your business’ most valuable asset, learn how to get ahead of the compliance curve. Our cannabis lawyers have been guiding clients through agency litigation and enforcement for a long time, and we are here to help. To learn more about how to avoid the time, effort, and cost of agency litigation, and how to navigate litigation against the state when needed, please attend our free webinar entitled “It Could Happen to You: Cannabis Agency Litigation and Enforcement” at noon Pacific on April 23, 2019. Featuring Harris Bricken lawyers Daniel Shortt (Washington), Jihee Ahn (Oregon), and Griffen Thorne (California), this webinar will provide an overview of agency enforcement and litigation against cannabis companies.

Drawing from their experiences across all west coast states, the panelists will discuss:

  • Inter-agency appeals
  • Administrative litigation and the Administrative Procedure Act
  • State enforcement priorities and communicating with state authorities in the event of a violation
  • State court litigation against agencies
  • Enforcement actions and written and verbal notices of violation against licensed operators and unlicensed companies and how to mitigate early and often

Moderated by Vince Sliwoski, the panelists will address audience questions throughout the presentation. To register for the webinar, please go here. Please feel free to write to firm@harrisbricken.com with any questions.

We hope you can join us!



source https://www.cannalawblog.com/cannabis-agency-litigation-free-webinar-april-23/

Wednesday, March 27, 2019

Going Postal: USPS Provides Guidance on Mailing Hemp-CBD

Recently the United States Post Office (“USPS”) issued an advisory on “Acceptance Criteria for Cannabidiol (CBD) Oil and Products Containing CBD.” Those criteria are as follows:

1. A signed self certification statement, subject to the False Statements Act (18 U.S.C. § 1001). Statements must be printed on the mailer’s own letterhead, must be signed by the mailer, and must include the text “I certify that all information furnished in this letter and supporting documents are accurate, truthful, and complete. I understand that anyone who furnishes false or misleading information or omits information relating to this certification may be subject to criminal and/or civil penalties, including fines and imprisonment.”

This first prong is straight forward. The mailer must include a sworn statement that all the related documents are accurate and truthful and include the above quote indicating an understanding of the penalties that come along with lying to a federal agency.

2. The industrial hemp producer possesses a license issued by the Department of Agriculture, for the state where the Post Office/acceptance unit is located, which includes documentation identifying the producer by name and showing the mailer is authorized by the registered producer to market products manufactured by that producer.

The second prong is a little more complicated. It requires that the hemp producer hold a license from the state Department of Agriculture where the Post Office or acceptance unit is located. This statement fails to consider cases where hemp or hemp products are shipped from a state that is different than the state of cultivation. Consider an online hemp retailer operating out of New York. New York has an industrial hemp program but is not a major hemp growing state so our retailer sources products that were produced and processed in Colorado. The retailer has done her due diligence and has copies of each farmer’s license to cultivate hemp. However, based on the fact that she uses hemp cultivated in another state, it does not appear that she could comply with this prong. Her best option is likely to include copies of the Colorado licenses with her shipments.

The second prong also requires documentation showing that the mailer is authorized by the register producer to “market products.” A letter from the producer could likely satisfy this requirement but it may also prove challenging for retailers who may not have a direct relationship with the producers who are growing hemp that is used in Hemp-CBD products.

3. The industrial hemp, or products produced from industrial hemp, contains a delta-9 THC concentration of not more than 0.3% on a dry weight basis.

The third prong requires that the hemp or hemp product has less than 0.3% THC concentration. This means that both raw hemp and products derived from hemp must have a THC concentration of less than 0.3%. Usually, these test results are contained in a Certificate of Analysis (“COA”). That means that each shipment of hemp or hemp products should have the corresponding test results for that lot or batch.

Marijuana Moment first reported on the new guidance from USPS. We’ve written about how USPS lost an administrative appeal over the mailability of shipping Hemp-CBD before so it’s not as if this new guidance means that the USPS will now allow CBD to be mailed. I read the guidance to provide insight as to what the USPS is looking for when it finds a shipment of hemp or Hemp-CBD. This guidance is also only temporary and specifically states that it may be altered or rescinded as other federal agencies figure out exactly how to regulate hemp. What this letter does not do is prevent state-level law enforcement from seizing hemp shipments, as was recently the case in Idaho. State agencies are not bound by USPS memos.

For now, it’s best for industry stakeholders to try their best to comply with this guidance by providing the sworn statement, a copy of any licenses associated with hemp being mailed, and a copy of any COAs associated with the hemp or hemp products.



source https://www.cannalawblog.com/going-postal-usps-provides-guidance-on-mailing-hemp-cbd/

Tuesday, March 26, 2019

The Battle Over the HARVEST Trademark for Cannabis Retail

cannabis trademark retailI’ve written extensively about trademark litigation matters involving cannabis brands, but up until now, the trend in these lawsuits has been well-known non-cannabis companies suing cannabis companies. To read more about these cases, see the following posts:

But a new type of cannabis trademark litigation is starting to crop up, with cannabis companies suing each other for trademark infringement. This type of litigation will be extremely illuminating because until now, many theories upon which cannabis businesses have relied to acquire trademark protection have not been formally tested. We do not yet know how courts will treat the purported trademark rights owned by cannabis businesses, but the ongoing litigation between Harvest Dispensaries Cultivation & Production Facilities, LLC, based out of Arizona (I’ll refer to them as “Harvest of Arizona”), and Harvest on Geary, Inc. / Harvest Off Mission, Inc., based here in San Francisco (I’ll refer to them as “Harvest of California”), could provide us with some guiding case law.

The lawsuit has multiple facets, but to summarize, in 2017 Harvest of Arizona sued Harvest of California in Arizona alleging that Harvest of California stole the HARVEST name and logo. This lawsuit alleged trademark infringement, intentional interference with contract and with business relations, conversion, unfair competition and misappropriation of trade secrets, fraud, violation of Arizona’s Racketeering Act, violation of Arizona’s Consumer Fraud Act and unjust enrichment. In its complaint, Harvest of Arizona, which was established in 2011 and began using the HARVEST mark in 2012, claimed to own retail dispensaries and cultivation/production facilities in Arizona, Nevada, Illinois, Maryland, California, Massachusetts, Michigan, and Florida. It had no presence in California.

Fast forward to 2018, when Harvest of Arizona announced its plans to expand into California. At this point, Harvest of California, which owns California state trademarks for the HARVEST name, sued Harvest of Arizona in California Superior Court for trademark infringement and unfair competition in California. Harvest of California notes in its complaint that this is a simple case of trademark infringement but that because the parties are in the cannabis industry, only state law applies. Federal trademark law is not applicable.

These cases are illustrative of just how complex the issue of trademark protection in the cannabis industry really is. The fact that cannabis is regulated on a state-by-state basis, with operators legally unable to place their cannabis products into the stream of interstate commerce, creates what I like to think of as “silos” of trademark protection. Cannabis businesses can only obtain trademark protection for their cannabis goods and services in the states in which they legally operate. So, in theory, it is possible for a company to have lawful rights to a trademark in one state, but infringe on another party’s mark by moving their brand into another state.

And that could very well turn out to be the case for the two Harvest entities. Although Harvest of Arizona allegedly used the HARVEST mark first, they only used the mark in Arizona, and perhaps a couple of other states, but not California. Harvest of California claims to have made first use of the HARVEST mark for cannabis retail services in California, and priority for trademark rights depends on a party’s date of first use in the state in which they are claiming those rights.

It is also important to accurately state your date of first use on your trademark filing, so as not to raise allegations that your trademark was obtained improperly. It’s critical to understand your state’s trademark law as well as the requirements for trademark protection so that your state trademark registration is actually worth something. Typically, state trademark applications do not undergo a great deal of scrutiny and it is common for trademark registrations to issue improperly. Those registrations will not stand up in litigation.

For some additional reading on the topic of how to choose an enforceable brand that won’t get you sued, see the following:



source https://www.cannalawblog.com/the-battle-over-the-harvest-trademark-for-cannabis-retail/

Monday, March 25, 2019

Are CBD Food and Drinks Really Not Legal? Really?

We advise some of the largest companies in the U.S. on hemp-derived cannabidiol (hemp-CBD) products. Those companies are filled with lawyers, and the lawyers have many specializations. Most of them, however, have little or no familiarity with hemp-CBD, and that is why they reach out and hire us. In the preliminary emails and phone calls, a very common question those lawyers ask is this: “The FDA has stated that it is ‘not legal’ to introduce THC or CBD products into the marketplace. What are we are missing?” It’s a great question, of course. Our typical explanation is along the lines below.

The FDA has taken a “not legal” position on hemp-CBD in consumables through its oft-cited FAQ and elsewhere. This FDA position is generally understood as “informal guidance” or a “statement of policy”, or sometimes a “nonlegislative rule” or an “interpretive rule”, which by any name does not have the force of law. FDA commonly issues informal guidance as its primary method of policy-making, which means that the agency does not undertake the Administrative Procedure Act (APA) process of “notice and comment” rulemaking in many cases. This has been FDA custom for a long time.

fda cbd hemp food beverage

The recent legalization of industrial hemp and sudden proliferation of related consumable products is the classic example of FDA choosing the “guidance” route over binding rulemaking. The underpinning administrative philosophy here is that nonbinding, informal guidance allows the agency to efficiently deploy resources, while maintaining administrative flexibility. The latter is going to be key with CBD, given the intense public interest in that decidedly safe compound.

Someone could (and might) sue FDA if FDA were to take an enforcement action based solely on the fact that a food or beverage product containing Farm Bill hemp-CBD were sold in commerce. Would they win? I’m guessing not. But the question for the courts would be what level of deference to afford FDA, and the law is somewhat unclear on that today. Some commentators believe that Congress needs to clarify the issue, arising from a line of cases known as Chevron and Mead. But the fact remains that FDA hasn’t taken any enforcement against these products since January 4 to our knowledge, and that very limited enforcement was taken under unclear circumstances. We believe that FDA will likely continue to act where people make health claims that violate the FD&C Act. However, that’s a universal issue and not specific to hemp-CBD.

Many people are taking the considered position that hemp-derived CBD products do not violate the FD&C Act. Others are just moving ahead in the marketplace without thinking hard at all, given the proliferation of products and seemingly relaxed administrative regime. Interestingly, the position that these products are lawful under the FD&C Act was FDA’s original position as well. The agency went even further last fall, in fact, with the stated position that CBD should not be controlled in any sense. Upon running that by DEA, however, the latter agency advised that removing controls from CBD would violate international treaties to which the U.S. in a signatory. We summarized that saga here.

FDA is currently slated to hold hearings next month on CBD in food and beverage products. This was scheduled after letters from congresspeople, on the agency understanding that “Congress wants there to be a pathway for CBD available.” That seems to be the prevailing sentiment among industry, consumers, and almost everyone else — including FDA.

So what does all of this mean? It means that from its current, informal position, FDA appears to be moving toward solutions for hemp-CBD in the marketplace, rather than in the opposite direction (via protracted APA rulemaking to formally limit CBD products). This development, along with the apparent regime of FDA nonenforcement, has emboldened many businesses–including some very large companies–to move in now and gain a first mover advantage. As a law firm that has worked in and around cannabis for almost a decade, we love it. And we are definitely cheering for them.



source https://www.cannalawblog.com/are-cbd-food-and-drinks-really-not-legal-really/